Drug Shortage Report for NORDITROPIN NORDIFLEX

Last updated on 2023-09-01 History
Report ID 178319
Drug Identification Number 02334852
Brand name NORDITROPIN NORDIFLEX
Common or Proper name NORDITROPIN NORDIFLEX
Company Name NOVO NORDISK CANADA INC
Market Status MARKETED
Active Ingredient(s) SOMATROPIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size EA
ATC code H01AC
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-06-01
Actual start date 2023-06-08
Estimated end date 2023-08-30
Actual end date 2023-08-31
Shortage status Resolved
Updated date 2023-09-01
Company comments Norditropin® FlexPro™ will be available for impacted 5 mg patients to transition to. For any questions or concerns, please contact our Customer Care at 1-800-465 4334.
Health Canada comments
Tier 3 Status No
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-09-01 English Compare
v10 2023-08-31 French Compare
v9 2023-08-31 English Compare
v8 2023-06-14 French Compare
v7 2023-06-14 English Compare
v6 2023-06-09 English Compare
v5 2023-06-08 French Compare
v4 2023-06-08 English Compare
v3 2023-06-02 English Compare
v2 2022-12-14 French Compare
v1 2022-12-14 English Compare

Showing 1 to 11 of 11